COUR vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 23, 2026

COUR

68.8
AI Score
VS
COUR Wins

UTI

40.9
AI Score

Investment Advisor Scores

COUR

69score
Recommendation
HOLD

UTI

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric COUR UTI Winner
Forward P/E 6.1463 28.6533 COUR
PEG Ratio 0 1.9084 Tie
Revenue Growth 59.6% 7.2% COUR
Earnings Growth 0.0% -78.9% COUR
Tradestie Score 68.8/100 40.9/100 COUR
Profit Margin -15.4% 3.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

COUR 1M: -17.8% · 3M: -13.9% UTI 1M: -8.7% · 3M: -60.6%

Current Technical Phase

COUR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.4%), weak momentum, RSI 44

RSI (14): 43.6 · Price: $5.08

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.6%), weak momentum, RSI 32

RSI (14): 31.7 · Price: $19.03

Fundamentals Snapshot

Metric COUR UTI
Market Cap — —
Forward P/E 6.2 25.9
Trailing P/E — 30.6
Revenue (TTM) — —
Revenue Growth 0.6% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS -0.75 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, COUR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.